1. Aaronson PI, Robertson TP, Knock GA, Becker S, Lewis TH, Snetkov V, et al. Hypoxic pulmonary vasoconstriction: mechanisms and controversies. J Physiol. 2006;570(Pt 1):53–8.
2. Abman SH. Abnormal vasoreactivity in the pathophysiology of persistent pulmonary hypertension of the newborn. Pediatr Rev. 1999;20(11):e103–9.
3. Abman SH, Stevens T. Perinatal pulmonary vasoregulation: implications for the pathophysiology and treatment of neonatal pulmonary hypertension. In: Haddad G, Lister G, editors. Tissue oxygen deprivation: developmental, molecular and integrative function. New York: Marcel Dekker; 1996. p. 367–432.
4. Abman SH, Accurso FJ, Wilkening RB, Meschia G. Persistent fetal pulmonary hypoperfusion after acute hypoxia. Am J Phys. 1987;253(4 Pt 2):H941–8.
5. Abman SH, Chatfield BA, Rodman DM, Hall SL, McMurtry IF. Maturational changes in endothelium-derived relaxing factor activity of ovine pulmonary arteries in vitro. Am J Phys. 1991;260(4 Pt 1):L280–5.